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Since mid-December 2019, several cases of a pneumonia like disease (with symptoms including fever, difficulty 
in breathing, cough and invasive lesions on both lungs) of unknown cause have emerged in the central Chinese 
city of Wuhan. Chinese authorities made a preliminary determination that the causative agent is a novel 
coronavirus(2019-nCoV). (1) Coronaviruses are enveloped RNA viruses belonging to Coronaviridae family and 
the order Nidovirales. This subfamily consists of four genera alphacoronavirus, betacoronavirus, 
gammacoronavirus and deltacoronavirus on the basis of their phylogenetic relationships and genomic structures. 
These subfamilies are broadly distributed for causing infections in humans and other mammals. (2) The 
alphacoronaviruses and betacoronaviruses infect only mammals. The gammacoronaviruses and 
deltacoronaviruses infect birds, but some of them can also infect mammals. The source of betacoronavirus 2019-
nCoV is still unknown, although initial cases have been linked with south Huanan seafood market. (3) Viral 
infections already known to produce similar symptoms are influenza, parainfluenza, Middle East respiratory 
syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS-CoV). (4) Laboratory investigations 
reported raised plasma levels of L2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα in patients. (1)  
 WHO reports day by day telling about spread of infection over entire globe. At time of writing this report, 2019-
nCoV infection in humans has been reported in Australia, France Japan, Malaysia, Nepal, Singapore, South 
Korea, Taiwan, Thailand and United States. (5) Pakistan, being a partner of China Silk Route, has two-way 
movement of citizens, is at major risk of epidemic in the country. It is, thus, important to have designed and 
developed diagnostic assay for confirmation of 2019-nCoV infection, if any. Authors surveyed for recent reports 
of 2019-nCoV and gathered significant genomic and molecular information about the virus. Data sources utilized 
for this purpose were GenBank, Global Initiative on Sharing All Influenza Data (GISAID) and virlogical.org. 
Corman et al. reported diagnostic assay using real-time RT-PCR. Method is good to differentiate between 2019-
nCoV and SARS-CoV. (6) But we used information given in by Huang et al. to develop 2019-nCoV RNA 
detection technique. This laboratory 
procedure should be performed in 
Biosafety level III settings. Details of 
assay are as following: 
RNA Extraction: Laboratories can 
extract virus RNA using any readymade 
RNA miniprep kit for downstream 
analysis. 
PCR Recipe: 
Forward primer: 5′-
TCAGAATGCCAATCTCCCCAAC-3′ 
Reverse Primer: 5′-
AAAGGTCCACCCGATACATTGA-3′ 
Mastermix: SuperScript III Platinum 
Sybr Green One-Step qRT-PCR Kit 
Amplification conditions of PCR reaction are given in Figure 1. 
Pathogen detection: Following real-time RT-PCR, presence of 2019-nCoV can be detected through real-time 
PCR results. 
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Figure 1: Amplification Conditions of RT-PCR 
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